| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |